Yahoo · Nov 2, 2026
5 Stocks Favored by Brokers Amid the Prevalent Market Turbulence
Amid market volatility, CBRL, ZIM and three other broker-favored stocks stand out for earnings strength, growth drivers and attractive valuations.
AD
NYSE · ADNT
Adient plc
Consumer Cyclical · Auto - Parts
$16.92
Down-$0.46 (-2.72%)
Updated Nov 4, 2026, 7:15 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.92B
- P/E ratio
- -6.32
- Dividend yield
- 0.00%
- 52-week range
- $15.91 – $27.32
- Volume
- 1.68M
- Avg. volume
- 1.15M
Price performance · ADNT
ADNT price history
1M range · 0 trading sessions · Daily adjusted prices
ADNT does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest ADNT news
The latest Smart Investors Daily articles mentioning ADNT.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ADNT research
Overview
Company profile and research snapshot.
Company profile
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $28.75
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 19, 2026 | Stifel | Buy | — |
| Oct 9, 2026 | Barclays | Equal-Weight | — |
| Oct 7, 2026 | UBS | Buy | — |
| Sep 15, 2026 | JP Morgan | Overweight | — |
| Aug 18, 2026 | Morgan Stanley | Equal-Weight | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 28, 2026
Adient (ADNT) Reports Next Week: Wall Street Expects Earnings Growth
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yahoo · Oct 27, 2026
3 Auto Stocks Facing North American Supply Chain Risk
Tariff talk between the U.S., Canada, and Mexico is no longer background noise. Potentially higher duties on steel and autos, along with tougher rules on where vehicles are built, could reshape how cars and parts move across borders. That kind of shock can hurt some holdings yet create room for others to gain ground. This piece walks through 3 stocks exposed to these trade headlines and explains why each one may warrant closer attention now. The three stocks below are just a starting sample...
Yahoo · Oct 23, 2026
Adient (ADNT) Stock Sees Modest Fair Value Cut As Analysts Trim Expectations
Adient’s updated analysis now points to a slightly lower modeled fair value, with the price target moving from US$29.55 to US$27.64. This shift sits alongside a split in analyst opinion, where some recently trimmed targets but still argue the stock could re-rate if execution, margins, and capital allocation improve. As you read on, you will see how these price target moves fit into the broader Adient narrative and what to watch to keep up with future updates. Stay updated as the Fair Value...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
